» Articles » PMID: 12691683

Three Instruments to Assess Fatigue in Children with Cancer: the Child, Parent and Staff Perspectives

Overview
Publisher Elsevier
Date 2003 Apr 15
PMID 12691683
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to develop and test three instruments to measure fatigue in children with cancer from the perspectives of the child, parents and staff. The study consisted of three phases: instrument development, content validation, and estimations of psychometric properties of the three fatigue instruments. One hundred forty-nine children between the ages of 7-12 years presently receiving chemotherapy for cancer, 147 parents and 124 staff participated in this study. The instruments demonstrated strong initial validity and reliability estimates. This study is the first to provide valid and reliable instruments to measure fatigue in children with cancer.

Citing Articles

[A systematic review of childhood cancer-related fatigue assessment tools based on the COSMIN guidelines].

Zhao Q, Wang Y, Bian L Zhongguo Dang Dai Er Ke Za Zhi. 2025; 27(2):184-191.

PMID: 39962781 PMC: 11838027. DOI: 10.7499/j.issn.1008-8830.2408132.


Fatigue in children who have recently completed treatment for acute lymphoblastic leukemia: a longitudinal study.

Walsh S, Mulraney M, McCarthy M, De Luca C Health Qual Life Outcomes. 2024; 22(1):27.

PMID: 38519964 PMC: 10960388. DOI: 10.1186/s12955-024-02241-2.


Fatigue Perception in Adolescents with Obesity and Their Caregivers.

Guerrini Usubini A, Bottacchi M, Bondesan A, Marazzi N, Castelnuovo G, Sartorio A J Clin Med. 2023; 12(13).

PMID: 37445303 PMC: 10342529. DOI: 10.3390/jcm12134268.


Sleep health behaviors in pediatric patients with newly diagnosed cancer.

Tucker P, Loew M, Russell K, Tynes B, Mandrell B, Witcraft S J Psychosom Res. 2023; 172:111413.

PMID: 37354749 PMC: 10751812. DOI: 10.1016/j.jpsychores.2023.111413.


Effectiveness of exergaming in reducing cancer-related fatigue among children with acute lymphoblastic leukemia: a randomized controlled trial.

Masoud A, Shaheen A, Algabbani M, AlEisa E, AlKofide A Ann Med. 2023; 55(1):2224048.

PMID: 37318119 PMC: 10274562. DOI: 10.1080/07853890.2023.2224048.